These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 3711665
1. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics. Bloom ET, Babbitt JT, Kawakami K. J Immunol; 1986 Jul 01; 137(1):172-8. PubMed ID: 3711665 [Abstract] [Full Text] [Related]
2. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F, Peri G, Villa A, Mantovani A. J Immunol; 1984 Feb 01; 132(2):936-44. PubMed ID: 6690624 [Abstract] [Full Text] [Related]
3. Prostaglandin E2, monocyte adherence and interleukin-1 in the regulation of human natural killer cell activity by monocytes. Bloom ET, Babbitt JT. Nat Immun Cell Growth Regul; 1990 Feb 01; 9(1):36-48. PubMed ID: 2139495 [Abstract] [Full Text] [Related]
4. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity. Luger TA, Uchida A, Köck A, Colot M, Micksche M. J Immunol; 1985 Apr 01; 134(4):2477-83. PubMed ID: 3882831 [Abstract] [Full Text] [Related]
15. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor. Uchida A, Moore M. J Natl Cancer Inst; 1984 Dec 01; 73(6):1285-92. PubMed ID: 6239944 [Abstract] [Full Text] [Related]
17. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity. Graves SS, Bramhall J, Bonavida B. J Immunol; 1986 Sep 15; 137(6):1977-84. PubMed ID: 2427588 [Abstract] [Full Text] [Related]
18. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. Tarkkanen J, Saksela E, Lanier LL. J Immunol; 1986 Oct 15; 137(8):2428-33. PubMed ID: 3093576 [Abstract] [Full Text] [Related]